Table 5

Therapeutic strategies for COVID-19 and outcomes

Study populationResults
Patients, n57
Medications, n (%)
Steroids (for COVID-19)19 (35)
Antibiotics35 (63)
 Azitromycin15 (27)
 >1 antibiotic16 (29)
Antivirals5 (9)
 Lopinavir/ritonavir3 (5)
 Darunavir/cobicistat1 (2)
 Remdesivir1 (2)
Immunomodulator3 (5)
 Tocilizumab1 (2)
 Rituximab1 (2)
 Ruxolitinib1 (2)
Hydroxychloroquine24 (44)
Oxygen therapy (higher intensity), n (%)
Overall30 (54)
 Nasal cannula18 (32)
 Non-invasive ventilation8 (14)
 Invasive mechanical ventilation4 (7)
Outcomes, n (%)
Death7 (12)
ARDS11 (19)
ICU admission4 (7)
Hospitalisation (no ICU)37 (65)
 Need for rehabilitation7 (17)
Duration of hospitalisation, median (IQR)
Hospital stay10 (7–22)
 ICU stay16 (10–19)
Rehab stay14 (11–15)
  • ARDS, acute respiratory distress syndrome; ICU, intensive care unit.